Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
-To identify the optimal dose of a seven-day course of twice-daily teriparatide as compared
to standard therapy for hypocalcemia in patients after total thyroidectomy and/or extensive
neck dissections (pharyngectomy, laryngectomy,unilateral, bilateral / central neck,
mediastinal lymph node neck dissections), with which serum calcium will be raised to
corrected serum calcium levels of 8-10.5mg/dL and maintained within this range until the end
of the treatment course.